Urolithiasis
0
Pipeline Programs
2
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
1100%
+ 3 programs with unclassified modality
Competitive Landscape
2 companies ranked by most advanced pipeline stage
CalyxoCA - Pleasanton
3 programsCVAC® SYSTEMN/A1 trial
CVAC® SYSTEMN/A1 trial
Steerable Ureteroscopic Renal EvacuationN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
CalyxoCVAC® SYSTEM
CalyxoSteerable Ureteroscopic Renal Evacuation
CalyxoCVAC® SYSTEM
Genesis TherapeuticsCiprofloxacin
Clinical Trials (4)
Total enrollment: 4,150 patients across 4 trials
Stone Clearance With Aspiration vs Other Technologies: a Real-world Evidence Study
Start: Mar 2026Est. completion: Apr 20291,000 patients
N/ANot Yet Recruiting
Trial of Ureteroscopy vs Steerable Continuous Flow Aspiration Technology
Start: Sep 2025Est. completion: Sep 2029150 patients
N/ANot Yet Recruiting
A Retrospective, Multi-center Real-world Study of Steerable Ureteroscopic Renal Evacuation (SURE) Procedure With the CVAC® System
Start: Feb 2024Est. completion: Sep 20263,000 patients
N/AActive Not Recruiting
Antibiotic Prophylaxis With Routine Ureteral Stent Removal
Start: Jan 2016Est. completion: Mar 2025
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space